Approved Hospital Formulary
Add Formweb to your mobile device
Approved Hospital Formulary
Search results for:
oxybutynin
oxybutynin
- Formulary Anti-cholinergic (Overactive Bladder) Formulary
- Restricted Oxytrol for Women --> Restrcited to NO SUB orders.
- Therapeutic Interchange
| Drug Name | Form | Strength | Formulary Unrestricted | Formulary Restricted | Non-Formulary | Interchange |
|---|---|---|---|---|---|---|
| Oxytrol for Women | FILM, EXTENDED RELEASE, TRANSDERMAL | 3.9 mg/24 hr | ||||
| Gelnique | GEL, TRANSDERMAL | 10% | ||||
| Ditropan | SYRUP, ORAL | 5 mg/5 mL | ||||
| Ditropan XL | TABLET, EXTENDED RELEASE, ORAL | 5 mg/24 hours, 10 mg/24 hours, 15 mg/24 hours | ||||
| Ditropan, Urotrol | TABLET, ORAL | 5 mg |
Last updated: Dec. 22, 2023
- Formulary, Not Routinely Stocked: Gelnique --> 10% gel
ORDERED FORMULATION
THERAPEUTIC INTERCHANGE
NOTES
oxybutynin (Oxytrol for Women)
oxybutynin (Gelnique)
Interchange Oxytrol patch to Gelnique 1 packet daily, when patient needs first Oxytrol Patch replaced in hospital, or if patch is originally ordered in hospital, unless “no substitution” is written; in the case of “no sub”, use Oxytrol for Women patch in place of Oxytrol.
Oxytrol for Women patch should be used for Oxytrol patch if no substitution is written, can be used on males as well as women, it is much lower cost. These two patches are essentially the same product, the Oxytrol for Women patch is not intended to be used OTC (self-care) for men because of recommended additional screening for BPH in men. There is no wording on the patch saying for women’s use only.
Reviewed: April 27, 2005, and July 28, 2009 (Gelnique), and October 28, 2014 (Oxytrol for Women)